Proton Pump Inhibitors Are Not Associated With Acute Kidney Injury in Critical Illness
Open Access
- 5 August 2016
- journal article
- research article
- Published by Wiley in The Journal of Clinical Pharmacology
- Vol. 56 (12) , 1500-1506
Abstract
Recent epidemiologic data linking proton pump inhibitor (PPI) use to acute and chronic kidney dysfunction is yet to be validated in other populations, and mechanisms have not been explored. Using a large, well phenotyped inception cohort of 15 063 critically ill patients, we examined the risk of acute kidney injury (AKI), as defined by the Kidney Disease Improving Global Outcomes criteria guidelines, according to prior use of a PPI, histamine‐2 receptor antagonist (H2RA), or neither. A total of 3725 (24.7%) patients reported PPI use prior to admission, while 905 (6.0%) patients reported H2RA use. AKI occurred in 747 (20.0%) and 163 (18.0%) of PPI and H2RA users respectively, compared to 1712 (16.2%) of those not taking acid suppressive medications. In unadjusted analysis, PPI and H2RA users had a 28% (95%CI 1.17‐1.41, P < .001) and 10% (95%CI 0.91‐1.30, P = .31) higher risk of AKI compared to those taking neither class of medication. However, in sequential models that included adjustment for demographics, cardiovascular comorbidities, indications for PPI use, and severity of illness, the effect of PPI on the risk of AKI was attenuated, and in the adjusted analysis, PPI was not associated with AKI (OR 1.02; 95%CI 0.91‐1.13, P = .73). The presence of sterile pyuria and hypomagnesemia did not modify the association between PPI use and AKI. In summary, after adjustment for demographics, illness severity, and the indication for PPI use, PPI use prior to admission is not associated with critical illness AKI.Keywords
Funding Information
- National Institute of Biomedical Imaging and Bioengineering (2R01 EB001659)
This publication has 25 references indexed in Scilit:
- Hypomagnesemia and the Risk of Death and GFR Decline in Chronic Kidney DiseaseThe American Journal of Medicine, 2013
- Unexpected Effect of Proton Pump InhibitorsCirculation, 2013
- Proton pump inhibitors and acute kidney injury: a nested case–control studyBMC Nephrology, 2013
- Proton-pump inhibitor use is associated with low serum magnesium concentrationsKidney International, 2013
- Risk of adverse cardiovascular outcomes and all-cause mortality associated with concomitant use of clopidogrel and proton pump inhibitors in elderly patientsCurrent Medical Research and Opinion, 2013
- A European Renal Best Practice (ERBP) position statement on the Kidney Disease Improving Global Outcomes (KDIGO) Clinical Practice Guidelines on Acute Kidney Injury: Part 1: definitions, conservative management and contrast-induced nephropathyNephrology Dialysis Transplantation, 2012
- Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary SyndromeCirculation, 2009
- Drug-induced tubulo-interstitial nephritis secondary to proton pump inhibitors: experience from a single UK renal unitNephrology Dialysis Transplantation, 2004
- The Epidemiology of Sepsis in the United States from 1979 through 2000New England Journal of Medicine, 2003
- Acute interstitial nephritis due to omeprazoleThe American Journal of Medicine, 1992